Bradley Saenger
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $502,944 | $1,143,513 |
| 2024 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $483,600 | $849,981 |
| 2023 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $465,000 | $904,913 |
| 2022 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $445,400 | $1,236,430 |
| 2021 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $425,000 | $1,769,885 |
| 2020 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $404,250 | $1,091,808 |
| 2019 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $385,000 | $578,112 |
| 2018 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $335,000 | $616,235 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.